BİŞGİN, A. Et Al. 2008. Clinical significance of TRAIL and its receptor expression profiles on CD4 CD25 Foxp3 Tregs and CD8 CD25 T cells in patients with rheumatoid arthritis. XVI Annual Congress of theEuropean Society of Gene Therapy .

BİŞGİN, A., YAZISIZ, V., Ülker, M., TERZİOĞLU, M. E., & ŞANLIOĞLU, S., (2008). Clinical significance of TRAIL and its receptor expression profiles on CD4 CD25 Foxp3 Tregs and CD8 CD25 T cells in patients with rheumatoid arthritis . XVI Annual Congress of theEuropean Society of Gene Therapy

BİŞGİN, ATIL Et Al. "Clinical significance of TRAIL and its receptor expression profiles on CD4 CD25 Foxp3 Tregs and CD8 CD25 T cells in patients with rheumatoid arthritis," XVI Annual Congress of theEuropean Society of Gene Therapy, 2008

BİŞGİN, ATIL Et Al. "Clinical significance of TRAIL and its receptor expression profiles on CD4 CD25 Foxp3 Tregs and CD8 CD25 T cells in patients with rheumatoid arthritis." XVI Annual Congress of theEuropean Society of Gene Therapy , 2008

BİŞGİN, A. Et Al. (2008) . "Clinical significance of TRAIL and its receptor expression profiles on CD4 CD25 Foxp3 Tregs and CD8 CD25 T cells in patients with rheumatoid arthritis." XVI Annual Congress of theEuropean Society of Gene Therapy .

@conferencepaper{conferencepaper, author={ATIL BİŞGİN Et Al. }, title={Clinical significance of TRAIL and its receptor expression profiles on CD4 CD25 Foxp3 Tregs and CD8 CD25 T cells in patients with rheumatoid arthritis}, congress name={XVI Annual Congress of theEuropean Society of Gene Therapy}, city={}, country={}, year={2008}}